Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urothelial Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT05701332
What this trial is testing

Effect of Intravesical B.C.G and Gemcitabine on Semen Quality and Testicular Volume

Who this might be right for
Urothelial Carcinoma BladderSperm Count, LowTestis; Fibrosis
Assiut University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05775471
What this trial is testing

Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer

Who this might be right for
Renal Pelvis and Ureter Urothelial Carcinoma
Jonsson Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Ended earlyNCT04131634
What this trial is testing

Stereotactic Ablative Radiation for Oligo-Progression of Urothelial Cancer

Who this might be right for
Urothelial Cancer
University of Texas Southwestern Medical Center 2
Not applicableUnknownNCT06321640
What this trial is testing

Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.

Who this might be right for
Breast CancerLung CancerMelanoma+5 more
European Institute of Oncology 265
Not applicableLooking for participantsNCT07514897
What this trial is testing

Detecting CREPT in Urine for Bladder Cancer Diagnosis and Monitoring

Who this might be right for
Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT04863885
What this trial is testing

Combination of Ipi/Nivo Plus Sacituzumab Govitecan in Metastatic Cisplatin Ineligible Urothelial Carcinoma Patients

Who this might be right for
Metastatic Urothelial Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 46
Testing effectiveness (Phase 2)UnknownNCT03529890
What this trial is testing

Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder

Who this might be right for
Urinary Bladder Cancer
Technical University of Munich 33
Testing effectiveness (Phase 2)Ended earlyNCT03869190
What this trial is testing

Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)

Who this might be right for
Urothelial CarcinomaBladder Cancer
Hoffmann-La Roche 272
Testing effectiveness (Phase 2)WithdrawnNCT06424717
What this trial is testing

Study of Avelumab and Tuvusertib in Participants With Advanced Urothelial Cancer That Has Progressed on Prior Anti-PD-(L)1 Therapy (JAVELIN DDRiver Bladder)

Who this might be right for
Urothelial Carcinoma
EMD Serono Research & Development Institute, Inc.
Testing effectiveness (Phase 2)Ended earlyNCT05219578
What this trial is testing

RTX-224 Monotherapy in Patients With Solid Tumors

Who this might be right for
Non Small Cell Lung CancerCutaneous MelanomaHead and Neck Squamous Cell Carcinoma+2 more
Rubius Therapeutics 7
Testing effectiveness (Phase 2)Active Not RecruitingNCT03504163
What this trial is testing

Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

Who this might be right for
Bladder Cancer
Memorial Sloan Kettering Cancer Center 45
Not applicableLooking for participantsNCT05646485
What this trial is testing

Bladder Cancer Screening Trial

Who this might be right for
Bladder CancerUrothelial CarcinomaHematuria+1 more
University of Texas Southwestern Medical Center 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT06822010
What this trial is testing

SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Urinary Bladder CancerUpper Tract Urothelial CancerUrothelial Cancer
Rutgers, The State University of New Jersey 28
Large-scale testing (Phase 3)Active Not RecruitingNCT03091660
What this trial is testing

S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer

Who this might be right for
Stage 0 Bladder Urothelial CarcinomaStage 0is Bladder Urothelial CarcinomaStage I Bladder Urothelial Carcinoma
SWOG Cancer Research Network 1,000
Not applicableLooking for participantsNCT06026189
What this trial is testing

Safely Reduce Cystoscopic Evaluations for Hematuria Patients

Who this might be right for
HematuriaUrothelial NeoplasmUrothelial Carcinoma+1 more
Erasmus Medical Center 1,100
Large-scale testing (Phase 3)Study completedNCT07413120
What this trial is testing

Efficacy and Safety of VasoClip® vs. WeckClip® for Robotic Urologic Surgery

Who this might be right for
Prostate Cancer (Adenocarcinoma)Kidney CancersUrothelial Cancer
Incheon St.Mary's Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07631884
What this trial is testing

Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor

Who this might be right for
Solid TumorsNeoplasms (Cancer / Tumors)Advanced Malignant Solid Neoplasm+13 more
Haihua Yuan 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT02989584
What this trial is testing

A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer

Who this might be right for
Bladder CancerMetastatic Bladder CancerUrothelial Carcinoma
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT02335424
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Urothelial Cancer (MK-3475-052/KEYNOTE-052)

Who this might be right for
Urothelial Cancer
Merck Sharp & Dohme LLC 374
Testing effectiveness (Phase 2)Study completedNCT03502785
What this trial is testing

INO-5401 + INO-9012 in Combination With Atezolizumab in Locally Advanced Unresectable or Metastatic/Recurrent Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma
Inovio Pharmaceuticals 35
Next Page